Cite
Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: Results from a phase III trial
MLA
Suttorp, M., et al. Front-Line Imatinib Treatment in Children and Adolescents with Chronic Myeloid Leukemia: Results from a Phase III Trial. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1308928551&authtype=sso&custid=ns315887.
APA
Suttorp, M., Schulze, P., Glauche, I., Göhring, G., Von Neuhoff, N., Metzler, M., Sedlacek, P., De Bont, E., Balduzzi, A., Lausen, B., Aleinikova, O., Sufliarska, S., Henze, G., Strauss, G., Eggert, A., Kremens, B., Groll, A., Berthold, F., Klein, C., … Thiede, C. (2018). Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: Results from a phase III trial.
Chicago
Suttorp, M, P Schulze, I Glauche, G Göhring, N Von Neuhoff, M Metzler, P Sedlacek, et al. 2018. “Front-Line Imatinib Treatment in Children and Adolescents with Chronic Myeloid Leukemia: Results from a Phase III Trial.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1308928551&authtype=sso&custid=ns315887.